Screening options and recommendations for colorectal cancer

Clinics in Colon and Rectal Surgery

Volumn 22, Issue 4, 2009, Pages 209-217

  Geiger, Timothy M ^a   Ricciardi, Rocco ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

colonoscopy; colorectal cancer; fecal occult blood test; Screening; virtual colonoscopy

Indexed keywords

EID: 78049344128     PISSN: 15310043     EISSN: 15309681     Source Type: Journal    
DOI: 10.1055/s-0029-1242460     Document Type: Article

References (55)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58 (2) 71-96
2. Geiger T M., Miedema B W., Geana M V., Thaler K, Rangnekar N J., Cameron G T. Improving rates for screening colonoscopy: Analysis of the health information national trends survey (HINTS I) data. Surg Endosc 2008 22 (2) 527-533
3. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008 103 (6) 1541-1549
4. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005 129 (2) 422-428
5. Allison J E., Sakoda L C., Levin T R. et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007 99 1462-1470
6. Fearon E R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990 61 (5) 759-767
7. Ahlquist D A., Skoletsky J E., Boynton K A. et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000 119 (5) 1219-1227
8. Tagore K S., Lawson M J., Yucaitis J A. et al. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clin Colorectal Cancer 2003 3 (1) 47-53
9. Calistri D, Rengucci C, Bocchini R, Saragoni L, Zoli W, Amadori D. Fecal multiple molecular tests to detect colorectal cancer in stool. Clin Gastroenterol Hepatol 2003 1 (5) 377-383
10. Imperiale T F., Ransohoff D F., Itzkowitz S H., Turnbull B A., Ross M E., Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004 351 (26) 2704-2714
11. Syngal S, Stoffel E, Chung D et al. Detection of stool DNA mutations before and after treatment of colorectal neoplasia. Cancer 2006 106 (2) 277-283
12. Duffy M J., van Dalen A, Haglund C et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003 39 (6) 718-727
13. Kim H J., Yu M H., Kim H, Byun J, Lee C. Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 2008 41 685-692
14. Winawer S, Stewart E, Zauber A et al. A comparison of colonoscopy and double contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 2000 342 1766-1772
15. Rex D K., Rahmani E Y., Haseman J H., Lemmel G T., Kaster S, Buckley J S. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997 112 (1) 17-23
16. Levin B, Lieberman D A., McFarland B et al, American Cancer Society Colorectal Cancer Advisory Group US Multi-Society Task Force American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008 134 (5) 1570-1595 (Pubitemid 351615355)
17. Cotton P B., Durkalski V L., Pineau B C. et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 2004 291 1713-1719
18. Rockey D C., Paulson E, Niedzwiecki D et al. Analysis of air contrast barium enema, computed tomographic colonography and colonoscopy: prospective comparison. Lancet 2005 365 305-311
19. Pickhardt P J., Choi J R., Hwang I et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003 349 2191-2000
20. Johnson C D., Harmsen W S., Wilson L A. et al. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterology 2003 125 (2) 311-319
21. Kim D H., Pickhardt P J., Taylor A J. et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 2007 357 (14) 1403-1412
22. Halligan S, Altman D G., Taylor S A. et al. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology 2005 237 (3) 893-904
23. Newcomb P A., Norfleet R G., Storer B E., Surawicz T S., Marcus P M. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992 84 (20) 1572-1575
24. Gross C P., Andersen M S., Krumholz H M., McAvay G J., Proctor D, Tinetti M E. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA 2006 296 (23) 2815-2822
25. Mandel J S., Church T R., Bond J H. et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000 343 (22) 1603-1607
26. Thiis-Evensen E, Hoff G, Sauar J et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark polyp study I. Scand J Gastroenterol 1999 34 414-420
27. Singh H, Turner D, Xue L, Targownik L E., Bernstein C N. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006 295 (20) 2366-2373
28. Winawer S J., Zauber A G., Ho M N. et al, The National Polyp Study Work Group. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993 329 (27) 1977-1981
29. Rex D K., Cutler C S., Lemmel G T. et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997 112 (1) 24-28
30. Pickhardt P J., Nugent P A., Mysliwiec P A., Choi J R., Schindler W R. Location of adenomas missed by optical colonoscopy. Ann Intern Med 2004 141 (5) 352-359
31. Barclay R L., Vicari J J., Doughty A S., Johanson J F., Greenlaw R L. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006 355 (24) 2533-2541
32. Johnson C D., Chen M H., Toledano A Y. et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008 359 (12) 1207-1217
33. Cotterill M, Gasparelli R, Kirby E. Colorectal cancer detection in a rural community. Development of a colonoscopy screening program. Can Fam Physician 2005 51 1224-1228
34. Kewenter J, Brevinge H. Endoscopic and surgical complications of work-up in screening for colorectal cancer. Dis Colon Rectum 1996 39 (6) 676-680
35. Ko C, Riffle S, Morris C et al. Complications after screening and surveillance colonoscopy [Abstract]. Gastroenterology 2007 132 A149
36. Ko C W., Riffle S, Shapiro J A. et al. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointest Endosc 2007 65 (4) 648-656
37. Levin T R., Zhao W, Conell C et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 2006 145 (12) 880-886
38. Nelson D B., McQuaid K R., Bond J H., Lieberman D A., Weiss D G., Johnston T K. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 2002 55 (3) 307-314
39. Rathgaber S W., Wick T M. Colonoscopy completion and complication rates in a community gastroenterology practice. Gastrointest Endosc 2006 64 (4) 556-562
40. Robinson M H., Hardcastle J D., Moss S M. et al. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut 1999 45 (4) 588-592
41. Segnan N, Senore C, Andreoni B et al, SCORE Working Group - Italy. Baseline findings of the Italian multicenter randomized controlled trial of once-only sigmoidoscopySCORE. J Natl Cancer Inst 2002 94 (23) 1763-1772
42. Atkin W S., Hart A, Edwards R et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 1998 42 (4) 560-565
43. Jain A, Falzarano J, Jain A, Decker R, Okubo G, Fujiwara D. Outcome of 5,000 flexible sigmoidoscopies done by nurse endoscopists for colorectal screening in asymptomatic patients. Hawaii Med J 2002 61 (6) 118-120
44. Levin T R., Conell C, Shapiro J A., Chazan S G., Nadel M R., Selby J V. Complications of screening flexible sigmoidoscopy. Gastroenterology 2002 123 (6) 1786-1792
45. Davila R E., Rajan E, Baron T H. et al, Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 2006 63 (4) 546-557
46. Vasen H F., Nagengast F M., Khan P M. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 1995 345 1183-1184
47. Konda A, Duffy M. Surveillance of patients at increased risk of colon cancer: inflammatory bowel disease and other conditions. Gastroenterol Clin North Am 2008 37 191-213
48. Thornton J G., Morris A M., Thornton J D., Flowers C R., McCashland T M. Racial variation in colorectal polyp and tumor location. J Natl Med Assoc 2007 99 (7) 723-728
49. Imperiale T F., Wagner D R., Lin C Y., Larkin G N., Rogge J D., Ransohoff D F. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000 343 (3) 169-174
50. Anderson J C., Alpern Z, Messina C R. et al. Predictors of proximal neoplasia in patients without distal adenomatous pathology. Am J Gastroenterol 2004 99 (3) 472-477
51. Betes Ibanez M, Munoz-Navas M A., Duque J M. et al. Diagnostic value of distal colonic polyps for prediction of advanced proximal neoplasia in an average-risk population undergoing screening colonoscopy. Gastrointest Endosc 2004 59 (6) 634-641
52. Zauber A, Lansdrop-Vogelaar I, Knudsen A et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the US Preventive Services Task Force. Ann Intern Med 2008 149 659-669
53. Gross C P., McAvay G J., Krumholz H M., Paltiel A D., Bhasin D, Tinetti M E. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med 2006 145 (9) 646-653
54. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008 149 (9) 627-637
55. Levin B, Lieberman D A., McFarland B et al, American Cancer Society Colorectal Cancer Advisory Group US Multi-Society Task Force American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008 134 (5) 1570-1595 (Pubitemid 351615355)